Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial-Reference-Cited by-同舟云学术

Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial

Published:2018-05-30 Issue:1 Volume:19 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Tanner Michael C.,Heller Raban,Westhauser Fabian,Miska Matthias,Ferbert Thomas,Fischer Christian,Gantz Simone,Schmidmaier Gerhard,Haubruck Patrick^ORCID

Funder

BonAlive

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-018-2681-9.pdf

Reference51 articles.

1. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res. 1998:S7–21. http://www.ncbi.nlm.nih.gov/pubmed/9917622

2. Moghaddam A, Zimmermann G, Hammer K, Bruckner T, Grutzner PA, von Recum J. Cigarette smoking influences the clinical and occupational outcome of patients with tibial shaft fractures. Injury. 2011. doi: https://doi.org/10.1016/j.injury.2011.05.011 .

3. Audige L, Griffin D, Bhandari M, Kellam J, Ruedi TP. Path analysis of factors for delayed healing and nonunion in 416 operatively treated tibial shaft fractures. Clin Orthop Relat Res. 2005;438:221–32. http://www.ncbi.nlm.nih.gov/pubmed/16131895